|
|
|||||||||||
Neuropsychiatric Genetics Unit, Department of Psychological Medicine, University of Wales College of Medicine, Cardiff
Department of Medical Genetics, Medical University Sofia, Bulgaria
Plovdiv Psychiatric Dispensary, Plovdiv, Bulgaria
Clinic of Child Psychiatry, Sofia, Bulgaria
Department of Psychiatry, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland
Department of Medical Genetics, Medical University Sofia, Bulgaria
Neuropsychiatric Genetics Unit, Department of Psychological Medicine, University of Wales College of Medicine, Cardiff, UK
Correspondence: Professor Michael J.Owen, Neuropsychiatric Genetics Unit, Department of Psychological Medicine, University of Wales College of Medicine, Cardiff CF14 4XN, UK. Tel: +44 (0)2920 74 3058; fax: +44 (0)2920 74 6554; e-mail: owenmj{at}cardiff.ac.uk
Declaration of interest Funding from the PPP Healthcare Medical Trust, London, UK. Collection of probands in Bulgaria funded by the Janssen Research Foundation and in the UK by the Medical Research Council.
Background Velo-cardio-facial syndrome (VCFS) is associated with interstitial deletions of chromosome 22q11. About 30% of patients with VCFS have psychosis, and the rate of these deletions in schizophrenia has been reported to be about 1%. Even higher rates of VCFS deletions have been reported for childhood-onset schizophrenia.
Aims To test the hypothesis that there is an increased rate of VCFS among patients with early-onset psychosis (age at onset <18 years). We screened 192 early-onset patients and 329 patients with adult-onset schizophrenia.
Method We genotyped the patients and 444 healthy controls for hemizygosity of five microsatellite markers and one single nucleotide polymorphism that map to the 22q11-deleted region.
Results One patient had a VCFS deletion, confirmed with semi-quantitative polymerase chain reaction. None of the controls showed a pattern of genotypes consistent with hemizygosity.
Conclusions VCFS may be less frequent among patients with psychosis than previously suggested; this rate is not increased among early-onset patients.
Related articles in BJP:
This article has been cited by other articles:
![]() |
N. M. Williams, H. Williams, E. Majounie, N. Norton, B. Glaser, H. R. Morris, M. J. Owen, and M. C. O'Donovan Analysis of copy number variation using quantitative interspecies competitive PCR Nucleic Acids Res., August 12, 2008; (2008) gkn495v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Williams, B. Glaser, N. Norton, H. Williams, T. Pierce, V. Moskvina, S. Monks, J. Del Favero, D. Goossens, D. Rujescu, et al. Strong evidence that GNB1L is associated with schizophrenia Hum. Mol. Genet., February 14, 2008; 17(4): 555 - 566. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Keen-Kim and N. B. Freimer Genetics and Epidemiology of Tourette Syndrome J Child Neurol, August 1, 2006; 21(8): 665 - 671. [Abstract] [PDF] |
||||
![]() |
N Craddock, M C O'Donovan, and M J Owen The genetics of schizophrenia and bipolar disorder: dissecting psychosis J. Med. Genet., March 1, 2005; 42(3): 193 - 204. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |